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Carboxypeptidase activity was studied in subcellular fractions from a transplantable rat insulinoma and 
found to be localised principally in the insulin secretory granule. The activity, which was specific for 
peptide substrates with C-terminal basic amino acids, appeared to be a single enzyme with Mr 54000. This 
enzyme differed with respect to size and pH optimum from other basic amino acid-specific 
carboxypeptidases, uch as carboxypeptidases B and N, and may be a secretory granule-specific enzyme 
involved in propolypeptide processing. 
Proinsulin Processing Carboxypeptidase 
1. INTRODUCTION 
The conversion of polypeptide hormone and 
neurosecretory peptide precursors commences 
after the arrival of the propolypeptide in the Golgi 
apparatus and continues for several hours during 
maturation of the secretory or storage granules [ 11. 
The site of cleavage of the peptide chain is usually 
marked by pairs of basic amino acids and seems to 
be brought about by two different enzymes. An en- 
dopeptidase cleaves on the carboxyl side of the 
basic amino acids, and an exopeptidase then trims 
off the remaining basic residues from the newly ex- 
posed C-terminus (review [2]). 
The ability to produce insulin from proinsulin 
by the combined action of trypsin and carboxypep- 
tidase B in vitro can be cited as evidence for such 
a mechanism. However, the enzymes operative in 
vivo have not been fully characterised both with 
respect o their subcellular localisation and nature. 
An endoprotease which is present in crude granule 
preparations from rat islets appears to be more 
closely related to lysosomal cysteine proteases than 
to trypsin [ 1,3,4]. Carboxypeptidase activity has 
also been demonstrated in crude granule prepara- 
tions [5]. It was not clear however, whether the lat- 
ter activity was associated with the insulin 
Granule Insulinoma Prohormone 
secretory granule or with other contaminating 
organelles. Because of the small amount of 
available starting material, it has not been possible 
to purify insulin secretory granules in sufficient 
yield from rat islets. This problem can be over- 
come by using a transplantable rat insulinoma. 
This tumour has been shown to consist almost ex- 
clusively of insulin secreting B cells [a], and to 
release insulin by a process which is similar to that 
in islets [7]. We describe here the distribution of 
carboxypeptidase activity in the various subcellular 
fractions of the insulinoma, and characterise the 
activity associated with the insulin granule 
fraction. 
2. EXPERIMENTAL 
Subcellular fractions designated Al-G from the 
transplantable rat insulinoma were prepared as in 
[8]. These subcellular fractions were collected from 
the 27% Percoll gradient shown in fig.1 of [8] and 
represented the following gradient fractions: (1) 
Al; (2-6) granules; (12,13) D; (14,15) E; (16,17) F; 
(20-24) G. Gradient fractions 2-6 which were 
enriched in granules were centrifuged on a 40% 
Percoll gradient (fig.2 of [8]) to generate fractions 
A2 (l-5), B (a-16) and C (17-24), where the 
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numbers in parentheses represent he gradient frac- 
tions. The purity of each subcellular fraction with 
respect o marker enzyme activity was determined 
as in [8]. 
The assay for carboxypeptidase activity was bas- 
ed on the fluorimetric measurement of carboxy- 
terminal arginine liberated from hippuryl-l- 
arginine (Sigma Chemical Co., Kingston Upon 
Thames, Surrey). Samples were diluted to about 
1 mg protein/ml in 0.1% (w/v) Brij 35 and 5 or 
10 pl aliquots were added to 245 or 240 ~1 of assay 
mixture containing 0.15 M sodium acetate (pH 
5.5) and 5 mM hippuryl-L-arginine in microcen- 
trifuge tubes. These were incubated at 37”C, and 
at certain time intervals, 25 ,J triplicate aliquots 
were removed and added to 25 ~1 0.1 M borate 
(pH 9) maintained at 100°C (in 5 cm x 9.4 cm 
glass tubes) in a dri-block (Tecam DB 3). After 
5 min at 100°C the samples were cooled to room 
temperature, and the liberated arginine was deter- 
mined using fluorescamine (Sigma Chemical Co.). 
To each tube was added 700 ~1 0.1 M borate (pH 
9) and, while mixing on a vortex mixer, 250~1 
fluorescamine solution [30 mg% (w/v) in 
acetonitrile]. The fluorescence was measured on a 
Perkin Elmer LS 5 fluorimeter (excitation, 390; 
emission, 465). The assay was checked for linearity 
with respect to time (up to 30 min), protein con- 
centration (up to 1Opg) and reaction product (up 
to 10 nmol). Protein was determined as in [9]. 
3. RESULTS 
A typical analysis of marker proteins in 
subcellular fractions Al to G is shown in table 1. 
Fraction AI is a lysosome-enriched fraction, A2 a 
granule fraction with lysosomal contaminants and 
C a granule fraction with mitochondrial con- 
tamination. Fraction B is the most enriched 
granule fraction. Fraction D contains the majority 
of mitochondrial enzyme activity, while fractions 
E and F represent fractions enriched with en- 
doplasmic reticulum and plasma membrane 
markers, respectively. Fraction G, at the top of the 
gradient, contains principally cytosolic proteins. 
The Golgi apparatus marker enzyme galactosyl 
transferase was concentrated in fraction F (not 
shown), [8]. Carboxypeptidase activity in these 
fractions was concentrated in fractions B and C 
where it attained its highest specific activity (table 
2). Activity in the lysosomal fraction AI, and for 
that matter in fractions D-F, could be readily ac- 
counted for by contamination of those fractions 
with granules. This suggests that the activity in 
fractions B and C is specifically associated with the 
insulin secretory granule. All further characterisa- 
tion of the enzyme activity was performed with 
fraction C. 
The carboxypeptidase activity had a pH op- 
timum of 5.6 to 5.8 (fig.l), a value which is similar 
to the predicted internal pH of the insulin secretory 
Table 1 
Marker protein content of the subcellular fractions of the transplantable rat insulinoma 
Subcellular 
fraction 
Total 
protein 
(mg) 
Insulin Aryl Cytochrome Catalasea NADPH- Lactate 5 ’ -Nucleo- 
(units/mg) sulphatasea oxidaseb cytochrome dehydro- tidaseb 
c reductaseb genaseb 
AI 
A2 
B 
C 
D 
E 
F 
G 
3.2 
. 
‘1.62 
8.8 5.17 
17.0 8.64 
37.7 2.70 
118.6 1.97 
93.6 1.17 
16.5 1.55 
396.0 0.01 
3.34 4.3 16.0 <O.l <l 123.0 
3.07 4.8 12.4 0.2 62.0 90.4 
1.41 11.4 9.0 1.4 60.0 65.9 
1.17 123.0 33.1 32.2 227.0 214.6 
0.65 195.0 11.2 26.9 30.0 116.4 
0.17 113.0 24.4 9.1 46.0 105.7 
0.12 16.4 28.1 14.6 139.0 220.5 
0.02 <O.l 2.8 0.7 554.0 6.2 
a~mol.min-l.mg-l; bnmol.min-l.mg -l. Fractions AI--G were as described in section 2. The assays were performed 
as described [8] 
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Table 2 Table 3 
Distribution of carboxypeptid~e activity in subcellular 
fractions of a tr~splantable rat insulinoma 
Effect of various additions on the carboxypeptidase 
activity of the insulin secretory granule 
Subcellular Carboxypeptidase 
fraction @mol. min-’ . mg-‘) 
Al 0.153 (1) 
A2 0.162 z!z 0.02 (5) 
B 0.741 + 0.08 (6) 
C 0.647 + 0.07 (7) 
D 0.222 z?z 0.06 (4) 
E 0.176 + 0.02 (4) 
F 0.162 t 0.01 (3) 
Fractions At-F were prepared and stored at -70°C. 
Each fraction was diluted in 0.1% Brij 35, and 10 pl 
(-10 pg) was assayed for carboxypeptidase activity 
granule [lo]. Activity could be readily solubilised 
by freezing and thawing in hypotonic buffer, with 
< 3% being associated with the granule membrane 
(not shown). 
The activity was stimulated about 3-fold by 
CoC12 and less markedly by higher concentrations 
of NiCI2 (table 3). The activity was inhibited by 
CuCla, HgCl2 (Kr 4 x lO_') and ~-~h~oromerc~lri- 
phenyl sulphonate (Xi 2 x lO_‘), and by the metal 
ion chelators EDTA and 1, lo-phenanthroline. 
Citrate at high concentrations inhibited the enzyme 
0’ , t / 
4.0 4.5 5,3 5.5 6.0 6.5 7.0 
PH 
Fig.1. Effect of pH on the carboxypeptidase activity of 
the insulin secretory granule. Fraction C was diluted into 
0.1% (w/v) Brij 35, and 10 pl (-10 fig) was assayed for 
carboxypeptidase activity in 0.15 M cacodylate buffer 
adjusted to the indicated pH-value with NaOH. The 
assay mixture contained 5mM hippuryl-L-~ginine. 
Addition 
NiCl2 
coc12 
cuc12 
ZnS04 
CaC12 
I-W12 
p-Chloromercuri- 
Cone. % Control 
(mM) activity 
10 133 
1 309 
1 17 
1 93 
1 96 
0.1 3 
phenylsulphonate 
~ethylmaleimide 
Iodoacetic acid 
Dithiothreitol 
Antipain 
Leupeptin 
Phenylmethylsulphonyl- 
0.1 6 
10 60 
10 99 
10 103 
10 98 
10 104 
fluoride 1 97 
Citrate 10 88 
EDTA 0.1 15 
l,lO-Phenanthroline 1 11 
Granule samples (5 pg in 0.15 M acetate, pH 5.5) were 
incubated in 10~1 for 2 h at 4°C with the indicated 
concentrations of effector substances; 240 pl 0.15 M 
acetate (pH 5.5) containing 5mM hippuryl-L-arginine 
was then added, and the samples incubated at 37°C for 
30 min. The liberated arginine was measured as in 
section 2. Each compound was tested in each experiment 
at: 10,~M, lOO~M, 1 mM and 10 mM. The values given 
are the average from 2 expt and represent the lowest or 
highest concentrations atwhich effects were observed 
activity. ZnS04, CaClz, N-ethylmaleimide, iodo- 
acetate and dithiothreitol had no effect, nor did 
the protease inhibitors antipain, leupeptin and 
phenylmethylsulphonyl ffuoride. 
The Mr of the granule-associated carboxypep- 
tidase activity was 54000 as determined by gel 
permeation chromatography on Ultragel AcA44 
(fig.2). 
The presence of other carboxypeptidases in the 
insulin granule was examined using the substrate 
hippuryl-L-phenylalanine under the same assay 
conditions. Activity, while detectable, was 
-SO-fold less than that measured using the basic 
amino acid containing substrate at the same con- 
centration (not shown). 
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Fig.2. Determination of the relative molecular mass of 
the insulin granule associated carboxypeptidase. About 
1 mg of fraction C was applied to a column (1.6 cm x 
7.5 cm) of Ultrogel AcA44, equilibrated in 0.05 M 
phosphate, 0.1 M NaCl (pH 7.5). The flow rate was 
3 cm/h; 2 ml fractions were collected and 50 ~1 samples 
assayed for carboxypeptidase activity. Blue dextran 
(V,), fl-galactosidase (M, 116W), bovine serum 
aibu~n {iw, 66500), ovaibumin (A& 45000), carbonic 
anhydrase (A!& 29000), soybean trypsin inhibitor (h& 
21 OOO), cytochrome c (Mr 12300) and tryptophan (6) 
were used to calibrate the column. The Kav value for the 
granule carboxypeptidase i  indicated (x), 
4. DISCUSSION 
The results are consistent with the presence of 
carboxypeptidase activity in the insulin secretory 
granule. The fact that the activity elutes as a single 
sharp peak on gel permeation chromatography 
(fig.2), and on DEAE-cellulose ion exchange 
chromatography (not shown) suggests that it is 
associated with a single enzyme, which has app. Mr 
54000. 
The insulin granule-associated carboxypeptidase 
differs from other carboxypeptidases involved in 
the removal of carboxy-terminal basic amino acids 
from proteins. Carboxypeptidase B (EC 3.4.12.3) 
is an exocrine pancreatic enzyme with MX 34300, 
and a pH optimum in the range pH 7-9 [ 1 l], while 
carboxypeptidase N is a plasma enzyme involved in 
the inactivation of bradykinin and kallidin 1121. 
The latter is a multi-subunit protease with Mr 
270000-280000 and a pH optimum around 7.7 
1131. However, similarities do exist between the 
carboxypeptidase of the insulin granule and car- 
boxypeptidase N in so far as they are both 
stimulated by Co2+ [14], and that the active 
subunit of carboxypeptidase N also has M, -54000 
]I51. 
Carboxypeptidase activities have been identified 
in chromaffin granules from bovine adrenal 
medullae, where they are purported to be involved 
in the processing of proenkephalin [16,17]. Nam- 
ed, enkephalin convertase, one such activity 
resembles that of the insulin granule in that it is ac- 
tivated by Co2+, inhibited by EDTA and 
1, IO-phenanthroline, and unaffected by leupeptin 
and antipain. It differs, however, in that it is not 
inhibited by HgC12 nor by p-chloromercuriphenyl- 
sulphonate [161. Inhibitor studies have distinguish- 
ed enkephalin convertase from carboxypeptidase 
N [18]. Tissue distribution studies have 
demonstrated its presence in the anterior pituitary, 
where it may be involved in the processing of pro- 
opiomelanocortin [ 191. Another chromaffin 
granule associated carboxypeptidase activity 
resembles that of the insulin granule enzyme, in be- 
ing inhibited by HgCl2 and p-chloromercuri- 
phenylsulphonate, but differs in that EDTA and 
1, lo-phenanthroline have little effect, while 
leupeptin and antipain inhibit the activity [17]. 
The differences reported for the chromaffin 
granule carboxypeptidases may reflect the purity 
of the granule preparations, since substantial car- 
boxypeptidase activity was observed in the 
lysosomal fraction of the adrenal medulla [ 161. On 
the other hand it is possible that distinct enzymes 
are present in the insulin and chromaffin granules. 
It could be that a family of c~boxypeptidase genes 
may exist and be expressed ifferently in different 
tissues, each enzyme being tailored for a specific 
peptide substrate. 
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